Maxillomandibular Advancement is an Effective Treatment for Severe Obstructive Sleep Apnea
Scott Boyd, DDS, PhD, is passionate about providing care to patients with obstructive sleep apnea (OSA). More specifically, his interest lies in treatment of patients with severe OSA who are not compliant with their CPAP treatment. An oral and maxillofacial surgeon, Dr. Boyd is a Research Professor at Vanderbilt School of Medicine. In 2009, Dr. Boyd received a Research Support Grant from the Oral and Maxillofacial Surgery Foundation for the treatment of sleep apnea by maxillomandibular advancement (MMA).
CPAP, or continuous positive airway pressure, is the first step in treating obstructive sleep apnea. In order to be effective, a patient must wear their CPAP mask every night for the rest of their lives. Patients with severe OSA who are not compliant with CPAP treatment are at higher risk for cardiovascular disease and elevated blood pressure.
Dr. Boyd’s research found that in patients with severe OSA, MMA was a safe and effective treatment, and may be equivalent in effectiveness to CPAP. MMA consistently produces a significant reduction in sleep disordered breathing and concomitant improvement in quality of life.
“Our long term data indicates that the effectiveness of MMA may be maintained on a long term basis, which is extremely important as OSA is considered a chronic disease that likely requires lifelong management,” said Dr. Boyd.
Treatment of OSA is truly a multidisciplinary endeavor. Dr. Boyd’s research includes collaboration with sleep medicine specialists who come from a number of different backgrounds, including neurology, pulmonary critical care, and psychiatry. “With these different perspectives, we hope to create an integrated pathway of care for patients with OSA.”
This multidisciplinary collaboration has brought the OMS specialty into the fold of OSA treatment. “Our specialty has been an essentially unknown entity in the treatment of OSA,” said Dr. Boyd. His goal is for the OMS specialty to have an appropriate, important place in the spectrum of OSA treatment.
Dr. Boyd’s research has appeared in the Journal of Oral and Maxillofacial Surgery (JOMS) and was awarded the Daniel M. Laskin Award for the most outstanding JOMS paper published in 2013. It also appeared as the lead article in the Journal of Clinical Sleep Medicine (JCSM) last July. “The publication in the JCSM will be seen by the entire sleep medicine community and highlights the important contribution that oral and maxillofacial surgeons can make to the care of OSA patients. Additionally, these publications should contribute significantly to our ability to gain future funding to continue this important research,” said Dr. Boyd.
Dr. Boyd emphasizes the critical role of the OMS Foundation in his research. The Research Support Grant provided the funding necessary for him to significantly enhance his clinical research program. “External sources of funding are extremely competitive. To have the OMS Foundation as a funding resource is tremendously important,” said Dr. Boyd.